Bioreactor for Enhanced T-cell Based Therapy of Melanoma

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$124,154.00
Award Year:
2004
Program:
SBIR
Phase:
Phase I
Contract:
1R43CA108381-01
Agency Tracking Number:
CA108381
Solicitation Year:
2004
Solicitation Topic Code:
n/a
Solicitation Number:
PHS2004-2
Small Business Information
AASTROM BIOSCIENCES, INC.
AASTROM BIOSCIENCES, INC., BOX 376, ANN ARBOR, MI, 48105
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
DOUGLAS Smith
(734) 930-5789
DSMITH@AASTROM.COM
Business Contact:
ALAN WRIGHT
(734) 930-5555
AWRIGHT@AASTROM.COM
Research Institution:
n/a
Abstract
DESCRIPTION (provided by applicant): Malignant melanoma is a significant and deadly form of cancer worldwide. Emerging evidence has shown that melanoma cells express tumor-associated antigens that are specifically recognized by the immune system. Melanom

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government